EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell–suppressive function in triple-negative breast cancer and other immunoregulatory settings

Amirhossein Rahmati iD, Shima Shahbaz, Mark Hnatiuk, Shokrollah Elahi iD

The Journal of Immunology · 02.11.2026 · 215 (11)

DOI: 10.1093/jimmun/vkag301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 13.11.2026. Verfasst von Amirhossein Rahmati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Foundational Sciences, Mike Petryk School of Dentistry, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Antigens, CD, Erythroid Cells, Apyrase, Triple Negative Breast Neoplasms. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Women and Children's Health Research Institute, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD71+ erythroid cells (CECs) expand in tumor-bearing hosts and suppress antitumor immunity, but the mechanisms underlying their immunoregulatory activity remain incompletely understood. Here, we identify CD39-mediated purine metabolism as a previously unrecognized suppressive pathway used by CECs. In the 4T1 model of triple-negative breast cancer, CD39 was enriched on CD45+ CECs in the spleen, bone marrow, and tumor microenvironment, whereas CD73 was restricted to a smaller subset. Single-cell RNA sequencing mapped Entpd1 and Nt5e expression across CEC subsets and revealed that CD39+ CECs exhibit a broad immunomodulatory transcriptional program. Functionally, CEC-associated CD39 hydrolyzed extracellular ATP to AMP. CD39+ CECs, but not their CD39− counterparts, suppressed T cell proliferation, and A2A adenosine receptor blockade partially restored these responses. Exogenous AMP also impaired T cell effector function through adenosine receptor signaling, supporting a model in which CEC-derived AMP promotes suppression through trans-cellular adenosine production and potentially direct receptor engagement. TGF-β increased CD39 and CD73 expression on CECs in association with SMAD3 activation, suggesting a potential reinforcing regulatory circuit. CD39+ CECs were also detected during early life, pregnancy, and infections, as well as in human bone marrow, indicating relevance beyond cancer. Collectively, these findings identify the adenosinergic axis as an additional component of the multifactorial suppressive program of CECs and reveal a broader mechanism through which erythroid progenitors regulate immunity across physiological and pathological settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, CDErythroid CellsApyraseTriple Negative Breast NeoplasmsPurinesT-LymphocytesAnimalsFemaleHumansReceptors, Transferrin5'-NucleotidaseMiceGPI-Linked ProteinsCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

CD39CD73adenosineerythroid progenitorspurine metabolism

Substanzen

Antigens, CDApyraseReceptors, TransferrinPurines5'-NucleotidaseCD71 antigenCD39 antigenGPI-Linked Proteinspurine

Autor:innen und Institutionen

  • Division of Foundational Sciences, Mike Petryk School of Dentistry, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Division of Hematology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, Alberta, Canada.
  • Glycomics Institute of Alberta, University of Alberta, Edmonton, Alberta, Canada.

ORCID-Profile: Amirhossein Rahmati, Shokrollah Elahi

Förderung

  • CIHR
  • Women and Children's Health Research Institute
  • Canadian Institutes of Health Research
  • Women and Children’s Health Research Institute

Zitieren

APA

Rahmati, A., Shahbaz, S., Hnatiuk, M., & Elahi, S. (2026). CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell–suppressive function in triple-negative breast cancer and other immunoregulatory settings. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag301

Vancouver

Rahmati A, Shahbaz S, Hnatiuk M, Elahi S. CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell–suppressive function in triple-negative breast cancer and other immunoregulatory settings. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag301

BibTeX
@article{Rahmati2026,
  author = {Rahmati, Amirhossein and Shahbaz, Shima and Hnatiuk, Mark and Elahi, Shokrollah},
  title = {CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell–suppressive function in triple-negative breast cancer and other immunoregulatory settings},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {11},
  doi = {10.1093/jimmun/vkag301}
}
Kostenlos starten →